Movement Disorders Society Viewpoint on Biological Frameworks of Parkinson’s Disease: Current Status and Future Directions
Movement Disorders. 2024-09-09; :
DOI: 10.1002/mds.30007

Lire sur PubMed
Kalia LV(1)(2)(3), Berg D(4), Kordower JH(5)(6), Shannon KM(7), Taylor JP(8),
Cardoso F(9), Goldman JG(10)(11), Jeon B(12), Meissner WG(13)(14)(15), Tijssen
MAJ(16), Burn DJ(17), Fung VSC(18)(19).
Author information:
(1)Krembil Research Institute, Toronto Western Hospital, University Health
Network, Toronto, Ontario, Canada.
(2)Division of Neurology, Department of Medicine, University of Toronto,
Toronto, Ontario, Canada.
(3)Tanz Centre for Research in Neurodegenerative Diseases, University of
Toronto, Toronto, Ontario, Canada.
(4)Department of Neurology, University Hospital Schleswig-Holstein, Campus Kiel
and Christian Albrechts-University of Kiel, Kiel, Germany.
(5)ASU-Banner Neurodegenerative Disease Research Center, Tempe, Arizona, USA.
(6)School of Life Sciences, Arizona State University, Tempe, Arizona, USA.
(7)Department of Neurology, University of Wisconsin School of Public Health,
Madison, Wisconsin, USA.
(8)Translational and Clinical Research Institute, Newcastle University,
Newcastle upon Tyne, United Kingdom.
(9)Movement Disorders Unit, Neurology Service, Internal Medicine Department, The
Federal University of Minas Gerais, Belo Horizonte, Brazil.
(10)Barrow Neurological Institute, Phoenix, Arizona, USA.
(11)JPG Enterprises LLC, Chicago, Illinois, USA.
(12)BJ Center for Comprehensive Parkinson Care and Rare Movement Disorders,
Chung-Ang University Health Care System, Hyundae Hospital, Namyangju-si, South
Korea.
(13)CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc,
Bordeaux, France.
(14)Univ. Bordeaux, CNRS, IMN, UMR5293, Bordeaux, France.
(15)Department of Medicine, University of Otago, Christchurch, and New Zealand
Brain Research Institute, Christchurch, New Zealand.
(16)Department of Neurology, Expertise Centre Movement Disorders, University
Medical Centre Groningen, Groningen, The Netherlands.
(17)Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne,
United Kingdom.
(18)Movement Disorders Unit, Department of Neurology, Westmead Hospital,
Westmead, New South Wales, Australia.
(19)Sydney Medical School, University of Sydney, Sydney, New South Wales,
Australia.
DOI: 10.1002/mds.30007
PMID: 39250594